IL6 and Alzheimer disease: For example, elevated levels of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), commonly linked to gut dysbiosis in Alzheimer’s disease, have also been reported in ALS patients and may accelerate disease progression [20, 21].